rs749085322
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PM5PP2PP3PP5
The NM_000053.4(ATP7B):āc.3505A>Gā(p.Met1169Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000632 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1169I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000053.4 missense
Scores
Clinical Significance
Conservation
Publications
- Wilson diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP7B | NM_000053.4 | c.3505A>G | p.Met1169Val | missense_variant | Exon 16 of 21 | ENST00000242839.10 | NP_000044.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152196Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000401 AC: 10AN: 249592 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461890Hom.: 0 Cov.: 30 AF XY: 0.0000646 AC XY: 47AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Wilson disease Pathogenic:2Uncertain:3
- -
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1169 of the ATP7B protein (p.Met1169Val). This variant is present in population databases (rs749085322, gnomAD 0.008%). This missense change has been observed in individual(s) with Wilson disease (PMID: 7626145, 20517649, 35220961, 36096368). ClinVar contains an entry for this variant (Variation ID: 210485). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ATP7B protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ATP7B function (PMID: 18203200). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces methionine with valine at codon 1169 of the ATP7B protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have shown that this variant causes a mild copper transport deficit (PMID: 18203200). This variant has been reported in individuals affected with Wilson disease (PMID: 18203200, 20517649, 36096368). This variant has been identified in 11/280976 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
- -
not provided Pathogenic:1
PP3, PM2, PM3, PS3_moderate -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at